Sponsor study identifier
observational
29
1 country
1
Study Start
March 24, 2020
Actual (reported)Primary Completion
January 31, 2021
Actual (reported)Study Completion
January 31, 2021
Actual (reported)MindMics earbuds is a new technology designed enhance an individual's quality of life by continuously monitoring the heart rate, stress, and blood pressure allowing patients to make decisions regarding their health. MindMics has a working prototype of the ear buds which will perform all the conventional tasks of earbuds (listen to music, etc.), but, in addition, will measure heart rate, stress, blood pressure. The earbuds capture the sounds made by the various cardiac structures pulsing and moving blood. The sound is caused by the acceleration and deceleration of blood and the turbulence developed during rapid blood flow.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 31, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 24, 2020
Actual (reported)January 31, 2021
Actual (reported)January 31, 2021
Actual (reported)October 18, 2021
Actual (reported)November 2, 2021
Actual (reported)Performance of the MindMics device for detecting Atrial Fibrillation based on inter-beat intervals
Sensitivity and specificity for detecting Atrial Fibrillation using inter-beat intervals and statistical measures based on inter-beat intervals
30 minutes
Patients with AFib
Normal patients without AFib
Patients rhythms was recorded using MindMics device
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Approximately 25 patients will be recruited for group 1 from inpatient or outpatient office visits. Approximately 25 patients will be recruited for group 2 prior to direct-current cardioversion allowing collection of data from before and after cardioversion to document differences in recordings during sinus rhythm after having successful cardioversion from atrial fibrillation.
Prisma Health
Sumter, South Carolina, 29150, United States
29 participants (actual enrollment reported by the registry).
First Submitted
October 18, 2021
First Posted
November 2, 2021
Study Start
March 24, 2020
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
January 31, 2021
Actual (reported)Study Completion
January 31, 2021
Actual (reported)Last Updated
November 2, 2021
Record last verified: 2021-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: